MEG3 and autoimmune disease: MEG3 could also activate or inhibit multiple signaling pathways, i.e., p53, TGFβ, Rb, and EZH2; and hence, the dysregulation of MEG3 expression was typical to solid tumors, inflammation, and autoimmune disease [34–38].